Recurrent Osteosarcoma Not Yet Recruiting Phase 1 / 2 Trials for Pepinemab (DB15155)

Also known as: Osteosarcoma recurrent / Osteogenic sarcoma recurrent

IndicationStatusPhase
DBCOND0028757 (Recurrent Osteosarcoma)Not Yet Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03205644VX15/2503 in Treating Younger Patients With Recurrent, Relapsed, or Refractory Solid TumorsTreatment